. 2015 Sep 17;14:120. doi: 10.1186/s12933-015-0283-3

Table 3.

Medical treatment at hospital discharge in 1062 patients with acute coronary syndrome

	NGT	IFG/IGT	Diabetes^A	Diabetes^B	P
No.	295	299	156	312
Female/male (n)	76/219	77/222	40/116	88/224	NS
Treatment at discharge (%)
Aspirin	97.8^l	97.5^l	96.7^l	89.4^c,f,i	<0.001
Clopidogrel	80.6^l	81.1^l	80.0^l	66.7^c,f,i	<0.001
Beta-blockers	94.7^l	96.1^l	97.3^l	95.0^c,f,i	NS
Calcium antagonists	9.2^l	14.6^l	9.3^l	24.6^c,f,i	<0.001
ACE inhibitors	51.2^f,i,l	62.6^c	70.7^c	63.8^c	<0.001
Angiotensin II receptor blockers	7.8^f,i,l	12.5^c,l	12.0^c,l	21.9^c,f,i	<0.001
Diuretics	8.9^f,i,l	16.8^l	16.7^l	42.5^c,f,i	<0.001
Statins	94.7^l	92.9^l	95.3^l	88.0^c,f,i	<0.01
Oral antidiabetic medication	0^i,l	0^i,l	7.3^c,f,l	56.1^c,f,i	<0.001
Insulin	0^l	0^l	0^l	52.7^c,f,i	<0.001
Oral antidiabetic medication and Insulin	0^l	0^l	0^l	26.3^c,f,i	<0.001

vs NGT, ^ap < 0.05, ^bp < 0.01, ^c p < 0.001; vs IFG/IGT, ^dp < 0.05, ^ep < 0.01, ^fp < 0.001; vs Diabetes OGTT, ^g p < 0.05, ^h p < 0.01, ⁱ p < 0.001; vs known diabetes, ^jp < 0.05, ^k p < 0.01, ^l p < 0.001

^APatients with diabetes discovered by OGTT

^BPatients with known diabetes at admission